Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close totalling over A$439m
Joining existing investors Hesta, Host Plus, CSL and QIC are the WA Government and Australia's sovereign investor in manufacturing capability, the National Reconstruction Fund Corporation (NRFC).
This final close of Brandon BioCatalyst Fund Six (BB6) will see Brandon Capital continue to invest in emerging biomedical technologies with strong commercial potential, translating these exciting discoveries into high-growth firms that positively impact human health.
To date, Brandon Capital has raised over A$1 billion across previous funds with notable Fund Six investments to date including AdvanCell (radiopharma), PolyActiva (glaucoma implant), Myricx Bio (ADC) and CatalYm (oncology).
Dr Chris Nave, Co-Founder and Managing Partner at Brandon Capital, 'We're excited to welcome the National Reconstruction Fund Corporation to our sixth fund, joining HESTA, Hostplus, CSL, QIC and the WA Government. Closing at $439 million, BB6 is our largest fund to date, and we remain committed to advancing breakthrough biomedical innovations through our unwavering scientific rigour and disciplined capital allocation, in pursuit of exceeding our investors' expectations.'
The firm has a track record of advancing its portfolio companies to commercialisation. Recent Brandon Capital portfolio company announcements include FDA approvals for a hypertension therapy from George Medicines and a left ventricular cardiac resynchronisation device developed by EBR Systems, with Q-Sera's blood collection tubes that produce high-quality serum faster and more reliably, recently approved in Japan.
Brandon Capital has an active portfolio of over 30 companies with 17 in clinical trials, four advancing or in-market, a promising preclinical pipeline and several actively contributing to Australia's high-skilled manufacturing sector growth.
Collectively supporting over 270 high-skilled Australian jobs are: surgical imaging innovator, OncoRes Medical, which has developed the first 'real-time' in cavity probe to improve cancer surgery outcomes; late-stage biotech PolyActiva, which is developing a long-term treatment for glaucoma, the second leading cause of blindness; needle-free patch for vaccine delivery Vaxxas, and radiopharmaceutical company AdvanCell, which is developing novel therapies for the treatment of a range of cancers.
NRFC CEO David Gall said, "Medical science has long development timelines, and it is important for the NRFC to make early and considered investments in the sector to attract the talent and capital that we will need to build our local commercialisation capabilities. If we want medical science jobs and industries to exist in Australia in ten years, we need to invest in them today."
Brandon Capital, headquartered in Australia with offices in the UK and US, has established a transcontinental presence that strengthens collaboration across regions. Australian portfolio companies gain access to UK/EU/US capital, expertise, and pharma networks, while international companies benefit from Australia's world-class clinical trial and research capabilities.
About Brandon Capital –
Brandon Capital is Australasia's leading life sciences venture capital firm, with offices in Australia, New Zealand, the US and the UK. Its unique model includes proprietary deal flow through Brandon BioCatalyst, a collaboration of over 50 of ANZ's leading medical research institutions, and its immersive corporate services structure enables portfolio companies to focus on research commercialisation. With more than 30 active companies in its portfolio, Brandon Capital has been sourcing and supporting the transition of world-leading science into world-leading businesses for nearly two decades.
For further information please contact
Media – AustraliaKirrily Davis, E: kdavis@bcpvc.com M: +61 (0)401 220228
Media - InternationalSue Charles, Charles Consultants E: sue.charles@charles-consultants.com M: +44 (0)7968 726585
Chris Gardner, E: Chris@CGComms.onmicrosoft.com M: +44 (0)7956 031077
About the National Reconstruction Fund Corporation (NRFC)
The NRFC invests to diversify and transform Australia's industry and economy. It has $15 billion to invest using direct loans, equity investments and loan guarantees. The NRFC investment mandate covers seven priority areas including value-add in resources; transport; medical science; defence capability; renewables and low emission technologies; value-add in agriculture, forestry and fisheries; and enabling capabilities.
The NRFC's role is to invest in Australian businesses and projects that design, refine and make in order to transform capability, grow jobs and a skilled workforce, and diversify our economy. NRFC is a corporate Commonwealth entity, established by the National Reconstruction Fund Corporation Act 2023 (NRFC Act) in September 2023.
For more information, visit nrf.gov.au
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
NinjaOne Appoints Geoff Davies as VP and Country Manager for Australia and New Zealand
Former ServiceNow and Elastic executive to drive NinjaOne's ANZ growth and customer success SYDNEY, July 28, 2025--(BUSINESS WIRE)--NinjaOne®, the automated endpoint management platform, today announced the appointment of Geoff Davies as Vice President and Country Manager for Australia and New Zealand (ANZ). Davies brings more than 15 years of experience leading high-performance sales teams across the region. As VP and Country Manager, Davies will be responsible for growing NinjaOne's business across Australia and New Zealand and continuing to make NinjaOne customers and partners wildly successful. Prior to NinjaOne, Davies led enterprise sales for ServiceNow in ANZ for more than a decade, scaling the region more than 8X. Under his guidance, his team consistently exceeded annual revenue targets and significantly grew the ANZ customer base. Davies also held senior sales leadership roles in other high-growth SaaS organizations, most recently as Regional Vice President of Commercial and Enterprise Sales for ANZ at Elastic. His leadership style focuses on collaboration, teamwork, and delivering meaningful value for the company and its customers. "Geoff is a proven sales leader with a deep understanding of the ANZ market and a passion for making his team and customers successful," said John Sapone, Chief Revenue Officer at NinjaOne. "As we continue to grow our presence in the region and deliver best-in-class value to IT teams and MSPs, Geoff will bring a unique perspective that will help NinjaOne, our customers, and our partners thrive." "Joining NinjaOne at this pivotal moment in rapid growth is the opportunity of a lifetime," said Davies. "The company's commitment to fostering community and customer success is unmatched in the industry, and it's clear that the leadership team is relentlessly focused on continuing to identify and solve customer pain points. I look forward to working with my fellow Ninjas and our partners to simplify IT for customers across Australia and New Zealand." NinjaOne is hiring globally and across all departments. To learn more, visit: About NinjaOne NinjaOne, the automated endpoint management platform, delivers visibility, security, and control over all endpoints for more than 30,000 customers in 130+ countries. The cloud-native NinjaOne platform simplifies endpoint management, patching, and visibility for environments at any scale. It is proven to increase productivity, reduce security risk, and lower costs. NinjaOne is obsessed with customer success and provides free and unlimited onboarding, training, and support. Try NinjaOne for free at View source version on Contacts Media Contact: press@ Sign in to access your portfolio
Yahoo
6 minutes ago
- Yahoo
Why Opendoor Stock Plummeted by Almost 8% on Monday
Key Points The company delayed a shareholder vote about its equity until August. It is considering a reverse stock split -- often not a good sign. 10 stocks we like better than Opendoor Technologies › Investors eagerly shut the door on real estate transaction platform developer Opendoor Technologies (NASDAQ: OPEN) on Monday. They didn't take kindly to news of an important vote on the company's future, and sent the share price down by almost 8% on the day. Meanwhile, the S&P 500 (SNPINDEX: ^GSPC) flatlined across the session, indicating that many other stocks would have been better pickups. Decision delayed Well before market open, Opendoor announced it was to adjourn the special stockholder meeting scheduled for that day. That convocation was intended for a vote on two proposals to effect a reverse stock split of the company's equity. The meeting was rescheduled for this coming Aug. 27. Opendoor investors are being polled on a pair of separate reverse-stock split plans. In its press release on the adjournment, the company stressed that approval of either won't necessarily mean ratification. In its words, "an approval would provide the company's board of directors with an option to pursue a reverse stock split only if the Board believes it is in the best interests of Opendoor and its stockholders, which includes seeking to ensure that Opendoor remains listed on Nasdaq." Nasdaq requires the closing prices of the stocks listed on its exchange to not fall below $1 per share for 30 consecutive days. Opendoor can fall back in compliance if its shares trade above that level for 10 trading days, at minimum, by Nov. 24 of this year. Doing the minimum Reverse stock splits are a common tool used by companies that find their shares underwater, i.e., below those minimum price stipulations. Although they aren't always a sign of a business in trouble, they are certainly not encouraging for shareholders or other folks who might otherwise be interested in the stock. Personally, I'd avoid Opendoor until it can right the ship with its equity. Should you invest $1,000 in Opendoor Technologies right now? Before you buy stock in Opendoor Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Opendoor Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 28, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Nasdaq. The Motley Fool has a disclosure policy. Why Opendoor Stock Plummeted by Almost 8% on Monday was originally published by The Motley Fool
Yahoo
6 minutes ago
- Yahoo
Digital Transformation Expert Sabine Bennett Joins FTI Consulting's Healthcare & Human Services Practice in Australia
SYDNEY, July 28, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Sabine Bennett as a Senior Managing Director in the Australian Healthcare & Human Services practice. Ms. Bennett, who is based in Sydney, has more than 16 years of experience delivering large, complex, technology-enabled transformation programs for health, aged care and life sciences clients. In her role at FTI Consulting, she will bring her deep sector expertise to help clients strategise, design and deliver digital solutions that improve patient and clinician experience, while working side-by-side with clients to embed these solutions and unlock their full value. 'Sabine has an excellent track record of working with organisations to create seamless digital experiences for consumers, providers and regulators,' said Nathan Schlesinger, Leader of the Healthcare & Human Services practice in Australia at FTI Consulting. 'Her strength lies in driving strategy to execution, delivering the right outcomes by putting people at the centre, while creating value for organisations.' The Healthcare & Human Services industry practice focuses on supporting clients with key industry agendas including sector reform and sustainability, digital transformation and productivity. The practice launched in January 2025 and has continued to add talent to build an industry-oriented capability that complements existing FTI Consulting services in policy and economics, cybersecurity, financial sustainability, restructuring and risk-oriented services. Commenting on her appointment, Ms. Bennett said, 'Australian organisations have great ambitions around Digital and AI to thrive in current conditions, but the execution is often challenging. I am excited to be scaling a practice with the skills and expertise our country needs to lead and support organisations through this. I can't wait to collaborate with my new colleagues as we work with health services and agencies to design and deliver digital solutions that work for patients, clinicians and communities.' Prior to joining FTI Consulting, Ms. Bennett was a Partner and the Digital Health Leader at a Big Four firm in Australia. Prior to that, she worked at NTT DATA Business Solutions, an IT services and consulting firm. About FTI Consulting FTI Consulting, Inc. is a leading global expert firm for organisations facing crisis and transformation, with more than 7,900 employees located in 32 countries and territories as of June 30, 2025. In certain jurisdictions, FTI Consulting's services are provided through distinct legal entities that are separately capitalised and independently managed. The Company generated $3.70 billion in revenues during fiscal year 2024. More information can be found at FTI Consulting, 22, Gateway1 Macquarie PlaceSydney, NSW 2000Australia+61 2 8247 8000 Investor Contact:Mollie Hawkes+ Media Contact:Rebecca Hine+61 402 235 in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
